1230050

Endo USA, Inc. — FEI 3001578003

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Malvern, PA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)